Comparative pharmacokinetics study of anastrozole after single administration and combination with celecoxib.

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. The Lancet. ,vol. 359, pp. 2131- 2139 ,(2002) , 10.1016/S0140-6736(02)09088-8

Bingjie Ma, Yuanyuan Zhang, Liqiang Gu, Yu Jiang, Pengyi Hou, Yan Zeng, Lunhui Zhang, Ping Ju, Kaishun Bi, Xiaohui Chen, Comparative pharmacokinetics of cyclophosphamide administration alone and combination with vitamin B6 in rats Biomedical Chromatography. ,vol. 29, pp. 62- 67 ,(2015) , 10.1002/BMC.3240

J.M. Nabholtz, A. Buzdar, M. Pollak, W. Harwin, G. Burton, A. Mangalik, M. Steinberg, A. Webster, M. von Euler, Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial Journal of Clinical Oncology. ,vol. 18, pp. 3758- 3767 ,(2000) , 10.1200/JCO.2000.18.22.3758

S.-H. Chang, C. H. Liu, R. Conway, D. K. Han, K. Nithipatikom, O. C. Trifan, T. F. Lane, T. Hla, Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 591- 596 ,(2004) , 10.1073/PNAS.2535911100

Jenifer R. Prosperi, Fredika M. Robertson, Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells. Prostaglandins & Other Lipid Mediators. ,vol. 81, pp. 55- 70 ,(2006) , 10.1016/J.PROSTAGLANDINS.2006.07.003

Qingguo Li, Daorong Wang, Jing Li, Ping Chen, Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas BMC Cancer. ,vol. 11, pp. 277- 277 ,(2011) , 10.1186/1471-2407-11-277

A.M.H Brodie, Q Lu, B.J Long, A Fulton, T Chen, N Macpherson, P.C DeJong, M.A Blankenstein, J.W.R Nortier, P.H.T.J Slee, J van de Ven, J.M.H.H van Gorp, J.R.J Elbers, M.E.I Schipper, G.H Blijham, J.H Thijssen, Aromatase and COX-2 expression in human breast cancers☆ The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 79, pp. 41- 47 ,(2001) , 10.1016/S0960-0760(01)00131-5

Bin Su, Edgar S. Díaz-Cruz, Serena Landini, Robert W. Brueggemeier, Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition. Steroids. ,vol. 73, pp. 104- 111 ,(2008) , 10.1016/J.STEROIDS.2007.09.011

Gurpreet Singh Ranger, Kefah Mokbel, COX-2 inhibitors and breast cancer. Anz Journal of Surgery. ,vol. 73, pp. 565- 566 ,(2003) , 10.1046/J.1445-2197.2003.02713.X

Ulrike Werner, Dierk Werner, Thomas Rau, Martin F Fromm, Burkhard Hinz, Kay Brune, Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans. Clinical Pharmacology & Therapeutics. ,vol. 74, pp. 130- 137 ,(2003) , 10.1016/S0009-9236(03)00120-6